---
figid: PMC5896787__nihms950525f2
figtitle: Emerging concepts for immune checkpoint blockade-based combination therapies
organisms:
- NA
pmcid: PMC5896787
filename: nihms950525f2.jpg
figlink: /pmc/articles/PMC5896787/figure/F2/
number: F2
caption: Upon TCR and CD28 engagement, CTLA-4 is rapidly up-regulated and binds with
  high affinity to B7 molecules. This leads to the CTLA-4 cytoplasmic tail recruitment
  of tyrosine phosphatases (SHP-1, SHP-2 and PP2a) that switch off TCR/CD28 downstream
  signaling pathways, otherwise promoting cell proliferation, differentiation, motility,
  acquisition of effector functions and glycolysis. On the other hand, PD-1 engagement
  induces LCK to phosphorylate its cytoplasmic tail with the consequent recruitment
  of tyrosine phosphatases (in particular SHP-2), which, besides down-regulating TCR/CD28
  activation, reduces phosphorylation of PD-1 itself. PD-1 downstream signaling pathway
  also leads to Cpt1a up-regulation and promotes fatty acid oxidation (FAO).
papertitle: Emerging concepts for immune checkpoint blockade-based combination therapies.
reftext: Roberta Zappasodi, et al. Cancer Cell. ;33(4):581-598.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9512126
figid_alias: PMC5896787__F2
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC5896787__F2
ndex: 08e037ef-def4-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5896787__nihms950525f2.html
  '@type': Dataset
  description: Upon TCR and CD28 engagement, CTLA-4 is rapidly up-regulated and binds
    with high affinity to B7 molecules. This leads to the CTLA-4 cytoplasmic tail
    recruitment of tyrosine phosphatases (SHP-1, SHP-2 and PP2a) that switch off TCR/CD28
    downstream signaling pathways, otherwise promoting cell proliferation, differentiation,
    motility, acquisition of effector functions and glycolysis. On the other hand,
    PD-1 engagement induces LCK to phosphorylate its cytoplasmic tail with the consequent
    recruitment of tyrosine phosphatases (in particular SHP-2), which, besides down-regulating
    TCR/CD28 activation, reduces phosphorylation of PD-1 itself. PD-1 downstream signaling
    pathway also leads to Cpt1a up-regulation and promotes fatty acid oxidation (FAO).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Prosbeta7
  - Mhc
  - zip
  - Tcr
  - sl
  - MKP-4
  - p38b
  - rl
  - ras
  - Ras64B
  - Ras85D
  - Vav
  - bsk
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - csw
  - wrd
  - wdb
  - mts
  - tws
  - Pp2A-29B
  - Lk
  - pk
  - Pc
  - HLA-C
  - CD274
  - TRBV20OR9-2
  - TRA
  - TRB
  - TRD
  - TRG
  - PLCG1
  - PLCG2
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - KRAS
  - HRAS
  - NRAS
  - VAV1
  - VAV2
  - VAV3
  - PRKCE
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - CPT1A
  - IL2
  - CTLA4
  - PTPN11
  - PTPA
  - PTPN6
  - LCK
  - CD28
  - ZAP70
  - PC
  - Cancer
---
